Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM Lim, M., Ye, X., Nabors, B., Piotrowski, A. F., Fisher, J., Desideri, S., Sims, M., Wen, P., Grossman, S. A. OXFORD UNIV PRESS INC. 2017: 31
View details for Web of Science ID 000415152500119